CLAIM CARD
This synthesis maps 12 included sources on Vitamin K2 vascular aging across 5 outcome classes and 13 cross-study disagreements. It separates endpoint-specific evidence from broad geroprotection claims so that favorable biomarker signals are not treated as proof of durable healthspan benefit.
Evidence grade: exploratory
Contradiction status: none
Publication: 465c8fd4-570f-4fb2-9b87-1059b5787f6b
Provenance: Derivation Web chain
Citation Support
source_1Peng 2025source_2Xu 2025source_3Placencia 2026source_4Zhao 2024source_5Vries 2025